SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006678
Filing Date
2018-08-08
Accepted
2018-08-08 07:01:51
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbbp-20180630x10q.htm 10-Q 1621764
2 EX-10.1 sbbp-20180630ex10118c88c.htm EX-10.1 125608
3 EX-31.1 sbbp-20180630ex31129f98d.htm EX-31.1 16488
4 EX-31.2 sbbp-20180630ex31221e6b3.htm EX-31.2 16492
5 EX-32.1 sbbp-20180630ex3217c3550.htm EX-32.1 17609
  Complete submission text file 0001558370-18-006678.txt   6132952

Data Files

Seq Description Document Type Size
6 EX-101.INS sbbp-20180630.xml EX-101.INS 1162807
7 EX-101.SCH sbbp-20180630.xsd EX-101.SCH 53622
8 EX-101.CAL sbbp-20180630_cal.xml EX-101.CAL 50050
9 EX-101.DEF sbbp-20180630_def.xml EX-101.DEF 156747
10 EX-101.LAB sbbp-20180630_lab.xml EX-101.LAB 463587
11 EX-101.PRE sbbp-20180630_pre.xml EX-101.PRE 330498
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-Q | Act: 34 | File No.: 001-37569 | Film No.: 18999747
SIC: 2834 Pharmaceutical Preparations